Search details
1.
IL-22 Binding Protein Promotes the Disease Process in Multiple Sclerosis.
J Immunol
; 203(4): 888-898, 2019 08 15.
Article
in English
| MEDLINE | ID: mdl-31292217
2.
Multiple sclerosis treatment effects on plasma cytokine receptor levels.
Clin Immunol
; 187: 15-25, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28941836
3.
A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis.
Hum Mol Genet
; 24(19): 5644-54, 2015 Oct 01.
Article
in English
| MEDLINE | ID: mdl-26188005
4.
Genetic variants are major determinants of CSF antibody levels in multiple sclerosis.
Brain
; 138(Pt 3): 632-43, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25616667
5.
Copy number variations across the blood-brain barrier in multiple sclerosis.
Ann Clin Transl Neurol
; 9(7): 962-976, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35560551
6.
Cerebrospinal fluid oligoclonal immunoglobulin gamma bands and long-term disability progression in multiple sclerosis: a retrospective cohort study.
Sci Rep
; 11(1): 14987, 2021 07 22.
Article
in English
| MEDLINE | ID: mdl-34294805
7.
Plasma protein profiling reveals candidate biomarkers for multiple sclerosis treatment.
PLoS One
; 14(5): e0217208, 2019.
Article
in English
| MEDLINE | ID: mdl-31141529
Results
1 -
7
de 7
1
Next >
>>